Krystal
Eyal Krystal, Kfar Saba IL
Patent application number | Description | Published |
---|---|---|
20120167597 | TEMPERATURE CONTROL SYSTEM FOR A LIQUID - A temperature control system ( | 07-05-2012 |
20120168357 | LIQUID FILTER DEVICE - Provided is a filter device for filtering liquid by passing it through one or more filtering media. The filter device comprises a cartridge defining a treatment region filled with said one or more filtering media and has a liquid inlet and a liquid outlet. A locking mechanism may be located within a liquid flow through the cartridge and configured to lock at least one of the liquid inlet and the liquid outlet upon expiration of life time of said at least one filtering medium. | 07-05-2012 |
20130247770 | BEVERAGE DISPENSING SYSTEM - This invention relates to a dispensing system, comprising a dispensing outlet ( | 09-26-2013 |
20140048469 | WATER FILTERING DEVICE - The invention relates to a filtering device for filtering running water from a pressurized water source, wherein two or more water treatment compartments or modules are arranged within a housing along a water flow path, each of the compartments or modules comprising at least one water treatment element or medium for performing a defined water treatment function. | 02-20-2014 |
Gerald Krystal, Vancouver CA
Patent application number | Description | Published |
---|---|---|
20100099737 | COMPOSITIONS AND METHODS FOR TREATING MYELOSUPPRESSION - The invention provides, in part, compositions and methods for protecting a hemopoietic cell, or for treating myelosuppression, in a subject in need thereof, by administering an effective amount of an inhibitor of a SH2-containing inositol-5′-phosphatase. | 04-22-2010 |
20100311094 | Allosteric Modulation Of Ship Polypeptides And Uses Thereof - This invention provides a method for identifying allosteric modulators of a SHIP polypeptide, wherein said SHIP polypeptide is contacted with a test compound, and wherein said SHIP polypeptide comprises an allosteric site selected from the group consisting of a SHIP C2 domain and a SHIP PH domain. | 12-09-2010 |
20120129925 | SHIP 1 MODULATORS - The present invention includes the use of pelorol, related compounds and pharmaceutical compositions thereof as modulators of SHIP 1 activity. This invention also provides novel terpene compounds capable of modulating SHIP 1 activity and methods of synthesis thereof. | 05-24-2012 |
John H. Krystal, Woodbridge, CT US
Patent application number | Description | Published |
---|---|---|
20140249173 | GLUTAMATE AGENTS IN THE TREATMENT OF MENTAL DISORDERS - Methods of treating mental disorders, including anxiety disorders such as obsessive-compulsive disorder, are provided. The methods comprise administering an effective amount of a glutamate modulator to an individual in need thereof. Also provided are methods of enhancing the activity of a serotonin reuptake inhibitor (SRI) comprising co-administering a glutamate modulator and a serotonin reuptake inhibitor. Pharmaceutical composition comprising a serotonin reuptake inhibitor and a glutamate modulator are also provided. | 09-04-2014 |
John H. Krystal, New Haven, CT US
Patent application number | Description | Published |
---|---|---|
20140256821 | INTRANNASAL ADMINISTRATION OF KETAMINE TO TREAT DEPRESSION - Methods and compositions for the treatment of treatment-resistant depression are described. More specifically, the invention demonstrates that intranasal administration of ketamine is effective to ameliorate the symptoms of depression in a patient who has not responded to an adequate trial of one antidepressant in the current episode and has recurrent or chronic depressive symptoms (>2 years). | 09-11-2014 |
20150056308 | INTRANASAL ADMINISTRATION OF KETAMINE TO TREAT DEPRESSION - Methods and compositions for the treatment of treatment-resistant depression are described. More specifically, the invention demonstrates that intranasal administration of ketamine is effective to ameliorate the symptoms of depression in a patient who has not responded to an adequate trial of one antidepressant in the current episode and has recurrent or chronic depressive symptoms (>2 years). | 02-26-2015 |
Mark Krystal, Westport, CT US
Patent application number | Description | Published |
---|---|---|
20140356863 | METHODS FOR DETERMINING THE SUSCEPTIBILITY OF A VIRUS TO AN ATTACHMENT INHIBITOR - The present invention provides novel compositions and methods that can be used for determining the susceptibility of virus to an attachment inhibitor. The present invention also provides methods for predicting whether an infected individual will respond to treatment with an attachment inhibitor, thereby allowing an effective treatment regimen to be designed without subjecting the patient to unnecessary side effects. | 12-04-2014 |